[Multibilly]

VLX1570 for R/R patients to go to trial

by Multibilly on Sun Oct 12, 2014 10:40 am

http://www.businesswire.com/news/home/20141007005819/en/FDA-Grants-Clearance-Proceed-Clinical-Study-%E2%80%93

"Vivolux, a pharmaceutical company specialized in cancer treatment, announced today [10/7/2014] that the FDA has granted clearance to proceed with VLX1570 to clinical phase I/II for treatment against relapsed and/or refractory multiple myeloma. Researchers at Vivolux have discovered a novel cancer drug target within the proteasome in tumor cells. This novel drug candidate inhibits tumor growth and prolongs survival in multiple myeloma in preclinical models that are resistant to conventional therapies"

[Dr. Peter Voorhees]

Re: VLX1570 for R/R patients to go to trial

by Dr. Peter Voorhees on Sun Oct 12, 2014 3:06 pm

This is a novel target in the ubiquitin-proteasome pathway with compelling preclinical science. Definitely worth a look for those in need of new ways of treating their myeloma. Let's hope for promising results in patients!

Pete